While the ongoing COVID-19 pandemic won’t have much of an impact on cash available for new biotech startups, it has…
Bionews Staff
Bionews, the owner and publisher of this site, employs science writers and editors, most of whom have PhDs in the life sciences, as well as veteran journalists, who ensure stories are well-written and easy to understand. Our stories undergo a comprehensive fact-checking and editing process to confirm accuracy, objectiveness, and thoroughness in order to best serve our audience of patients and caregivers.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Bionews Staff
European authorities must step up efforts to screen babies for a multitude of genetic disorders, a panel of experts suggested…
Eurordis, a Paris-based coalition of national rare disease associations across Europe, hosted its first all-virtual conference, bringing some 1,500…
As the number of Americans infected with COVID-19 surpasses one million, it’s no surprise that people with rare diseases —…
FFF Enterprises and BioNews announced today that both rare and orphan disease advocates are joining forces to provide patients with…
First, the bad news: If you’re one of the 30 million or so Americans with a rare disease, you probably…
Even with the coronavirus pandemic ravaging Europe and much of the world, patient advocate Lucia Monaco, PhD, of Italy…
The gleaming new Dutch headquarters of the European Medicines Agency (EMA), fronting Domenico Scarlattilaan in Amsterdam’s suburban Zuidas business…
Despite skyrocketing healthcare costs, President Trump is committed to protecting the 30 million or so Americans with rare diseases and…